.Africa is the proposed Internet generic Top-Level Domain (gTLD) for the African and Pan African communities and users wherever they may reside. The .africa gTLD serves as a regional domain for individuals and entities based in and out of Africa.
The .Africa gTLD has not yet been delegated to any organization as registry operator. The .Africa application that was submitted by DotConnectAfrica Trust is now the subject of an unresolved disagreement with ICANN (DCA Trust vs ICANN) following an Independent Review Panel (IRP) Process that was invoked by DCA Trust under ICANN’s accountability mechanism in October 2013. The IRP was administrated by the International Center for Dispute Resolution (ICDR) of the American Arbitration Association (AAA) New York, US.
DCA Trust had passed all the new gTLD applicant evaluation criteria, but before the Initial Evaluation (IE) result was issued, a Governmental Advisory Committee GAC Objection Advice that had been issued in Beijing in April 2013 was later accepted by the ICANN Board in early June 2013 which caused the ICANN Board to instruct ICANN staff that DCA Trust’s .Africa new gTLD application will not be approved. This had caused the non-completion of the evaluation of DCA Trust’s application; which then led DCA Trust to challenge the ICANN Board decision through a series of accountability mechanism.
The initial idea for the song came from David Paich. Jeff Porcaro explains the idea behind the song: "a boy is trying to write a song on Africa, but since he's never been there, he can only tell what he's seen on TV or remembers in the past."
David Paich said: "At the beginning of the '80s I watched a late night documentary on TV about all the terrible death and suffering of the people in Africa. It both moved and appalled me and the pictures just wouldn't leave my head. I tried to imagine how I'd feel about if I was there and what I'd do."
Musically the song took quite some time to assemble, as Paich and Porcaro explain:
Africa and De viris illustribus were partially inspired by Petrarch's visit to Rome in 1337. According to Bergin and Wilson (p. ix). It seems very likely that the inspirational vision of the Eternal City must have been the immediate spur to the design of the Africa and probably De viris illustribus as well. After returning from his grand tour, the first sections of Africa were written in the valley of Vaucluse. Petrarch recalls
The fact that he abandoned it early on is not entirely correct since it was far along when he received two invitations (from Rome and from Paris) in September 1340 each asking him to accept the crown as poet laureate. A preliminary form of the poem was completed in time for the laurel coronation April 8, 1341 (Easter Sunday).
DAKAR, Senegal (AP) — Senegal and Rwanda have signed an agreement with German company BioNTech for the construction of its first start-to-finish factories to make messenger RNA vaccines in Africa. BioNTech, which produces the Pfizer-BioNTech COVID-19 vaccine, said Tuesday that construction will start in mid-2022.
BioNTech, the co-creator of the Comirnaty COVID-19 vaccine alongside Pfizer, announced Tuesday it plans to begin construction of an mRNA vaccine manufacturing facility in Africa in the middle of next year, according to the company's news release ... improve medical care in Africa.
BioNTech has struck a deal with Rwanda and Senegal to begin construction of a “game changing” mRNA vaccine manufacturing facility in Africa next summer ... “State-of-the-art facilities like this will be life-savers and game changers for Africa,” said Dr Matshidiso Moeti, the regional director of the World Health Organization’s Africa office.
Germany's BioNTech, which developed a coronavirus jab with US pharmaceutical giant Pfizer, said Tuesday it aims to begin building a vaccine plant in Africa next year ... it aims to begin building a vaccine plant in Africa next year.
DAKAR, Senegal (AP) — Senegal and Rwanda have signed an agreement with German company BioNTech for the construction of its first start-to-finish factories to make messenger RNA vaccines in Africa. BioNTech, which developed the Pfizer-BioNTech COVID-19 vaccine, said Tuesday that construction will start in mid-2022.
FRANKFURT (Reuters) -BioNTech on Tuesday signed an agreement with the Rwandan government and Institut Pasteur de Dakar in Senegal on the construction of a first mRNA vaccine manufacturing facility in Africa starting in mid-2022, to help the continent ease health inequalities compared to other world regions.
... for communities in SouthAfrica ... The collaboration among Exxaro, Seriti and Eskom is exemplary of the possibilities achievable through co-operative and constructive relations between business and government in securing livelihoods and a future for South Africa,” Mgojo said.
German vaccine developer BioNTech said on Tuesday that it had signed a memorandum of understanding with the Rwandan government and the Institut Pasteur de Dakar for the construction of the first messenger ribonucleic acid (mRNA) vaccine production facility in Africa.
... the African Union, the timing and pricing for that potential supply; the Company’s plans to fill doses of mRNA-1273 in Africa; the Company’s plans to construct a manufacturing facility in Africa and the related investment; and the Company’s potential supply of mRNA-1273 to COVAX.
... and liberation from colonialism and imperialism, President Akufo-Addo noted that Russia, in the aftermath of the Cold War, has continued to increase its co-operation with Africa in several sectors such as health, energy, communications, mining, and railway construction.